Abstract |
A 65-year-old man was diagnosed with primary duodenal cancer and he underwent pancreaticoduodenectomy in June 2006. S-1 was administered as the postoperative adjuvant chemotherapy. A peritoneal disseminated recurrence was diagnosed together with a right reniportal node and right hydronephrosis in February 2007. A ureteral stent was inserted. DOC +S-1 combination therapy was administered from March 2007. Following progression of the recurrence, CDDP+S-1 combination therapy was administered from August 2007. Temporal diminution of the recurrence was achieved with radiotherapy from May to June 2009. Following re-progression of the recurrence, biweekly CPT-11 therapy was administered from February 2010. Weekly PTX therapy was administered from January 2011. The patient died due to progression of the recurrence in June 2011, 5 years after the operation. Our patient maintained a good quality of life and achieved long-term survival by combined modality therapy for peritoneal disseminated recurrence of duodenal cancer.
|
Authors | Akira Kabashima, Kensuke Kudo, Toshihiko Nakamura, Mizuki Ninomiya, Takayuki Hamatsu, Hirofumi Hasegawa, Chie Ushijima, Masayuki Kitamura |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy
(Gan To Kagaku Ryoho)
Vol. 39
Issue 12
Pg. 1969-71
(Nov 2012)
ISSN: 0385-0684 [Print] Japan |
PMID | 23267946
(Publication Type: Case Reports, English Abstract, Journal Article)
|
Topics |
- Aged
- Combined Modality Therapy
- Duodenal Neoplasms
(pathology, therapy)
- Fatal Outcome
- Follow-Up Studies
- Humans
- Male
- Peritoneal Neoplasms
(secondary, therapy)
- Recurrence
- Time Factors
|